CENTRAL VENOUS CATHETERISATION

This adverse event was reported 3019 times

These drugs are most commonly taken by patients reporting CENTRAL VENOUS CATHETERISATION:

# Drug Count
0 AMBRISENTAN 403
1 TREPROSTINIL 334
2 SILDENAFIL CITRATE 304
3 NATALIZUMAB 241
4 TADALAFIL 238
5 EPOPROSTENOL 194
6 MACITENTAN 145
7 SILDENAFIL 142
8 ECULIZUMAB 133
9 WARFARIN 124
See all common drugs associated with CENTRAL VENOUS CATHETERISATION

CENTRAL VENOUS CATHETERISATION is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 EPOPROSTENOL 194 0.0148
1 C1 ESTERASE INHIBITOR RECOMBINANT 67 0.0104
2 LARONIDASE 38 0.0092
3 ANTIHEMOPHILIC FACTOR (RECOMBINANT), FC FUSION PROTEIN 28 0.0074
4 ALGLUCOSIDASE ALFA 16 0.0066
5 IDURSULFASE 24 0.0060
6 ELOSULFASE ALFA 33 0.0060
7 LANADELUMAB-FLYO 18 0.0056
8 ETEPLIRSEN 12 0.0050
9 COAGULATION FACTOR IX (RECOMBINANT), FC FUSION PROTEIN 12 0.0048
See all drugs enriched for association with CENTRAL VENOUS CATHETERISATION